Access to Breast Cancer Diagnosis Act of 2023

Bill 118 s 2464, also known as the Access to Breast Cancer Diagnosis Act of 2023, aims to improve access to breast cancer diagnosis for women across the United States. The bill focuses on increasing funding for breast cancer screening programs, particularly for low-income and underserved communities.

One of the key provisions of the bill is the expansion of Medicaid coverage for breast cancer screenings, ensuring that more women have access to these life-saving tests. Additionally, the bill allocates funding for research into new and improved diagnostic tools for breast cancer, with the goal of increasing early detection rates and improving outcomes for patients.

The Access to Breast Cancer Diagnosis Act of 2023 also includes provisions to increase education and awareness about breast cancer, particularly among communities that may face barriers to accessing healthcare services. This includes funding for outreach programs and initiatives to promote regular screenings and early detection. Overall, the bill seeks to address disparities in breast cancer diagnosis and treatment, with the ultimate goal of reducing mortality rates and improving outcomes for women with breast cancer. By increasing access to screenings, funding research, and promoting education and awareness, the Access to Breast Cancer Diagnosis Act of 2023 aims to make a meaningful impact on the fight against breast cancer in the United States.